Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12Almirall

02 1Boehringer Ingelheim GmbH

03 3Eli Lilly

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lebrikizumabum

Brand Name : Ebglyss

Dosage Form : Solution For Injection

Dosage Strength : 250mg/2ml

Packaging :

Approval Date : 30/08/2024

Application Number : 69344

Regulatory Info : Allowed

Registration Country : Switzerland

blank

02

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lebrikizumabum

Brand Name : Ebglyss

Dosage Form : Solution For Injection

Dosage Strength : 250mg/2ml

Packaging :

Approval Date : 30/08/2024

Application Number : 69460

Regulatory Info : Allowed

Registration Country : Switzerland

blank

03

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lebrikizumab

Brand Name : Ebglyss

Dosage Form : Solution For Injection

Dosage Strength : 250mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

04

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lebrikizumab

Brand Name : Ebglyss

Dosage Form : Solution For Injection

Dosage Strength : 250mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

05

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lebrikizumab

Brand Name : Ebglyss

Dosage Form : Solution For Injection

Dosage Strength : 250mg/2ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

06

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lebrikizumab

Brand Name : Ebglyss

Dosage Form : Solution For Injection

Dosage Strength : 250mg/2ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

07

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lebrikizumab

Brand Name : Ebglyss

Dosage Form : Injectable Solution In Pre-Filled Syringe

Dosage Strength : 250MG

Packaging :

Approval Date : 21-12-2023

Application Number : 1231765001

Regulatory Info : Authorized

Registration Country : Spain

blank

08

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lebrikizumab

Brand Name : Ebglyss

Dosage Form : Injectable Solution In Pre-Filled Pen

Dosage Strength : 250MG

Packaging :

Approval Date : 21-12-2023

Application Number : 1231765007

Regulatory Info : Authorized

Registration Country : Spain

blank

09

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lebrikizumab

Brand Name : Ebglyss

Dosage Form : Solution For Injection

Dosage Strength : 250mg

Packaging :

Approval Date : 16-11-2023

Application Number : 28106848322

Regulatory Info : Prescription

Registration Country : Denmark

blank

10

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lebrikizumab

Brand Name : Ebglyss

Dosage Form : Solution For Injection

Dosage Strength : 250mg

Packaging :

Approval Date : 16-11-2023

Application Number : 28106848422

Regulatory Info : Prescription

Registration Country : Denmark

blank

11

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lebrikizumab

Brand Name : Ebglyss

Dosage Form : Solution For Injection

Dosage Strength : 250mg

Packaging :

Approval Date : 16-11-2023

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

12

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lebrikizumab

Brand Name : Ebglyss

Dosage Form : Solution For Injection

Dosage Strength : 250mg

Packaging :

Approval Date : 16-11-2023

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

13

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

IDARUCIZUMAB

Brand Name : PRAXBIND

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2.5G/50ML

Packaging :

Approval Date :

Application Number : 761025

Regulatory Info :

Registration Country : USA

blank

14

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

LEBRIKIZUMAB-LBKZ

Brand Name : EBGLYSS

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 250MG/2ML

Packaging :

Approval Date :

Application Number : 761306

Regulatory Info :

Registration Country : USA

blank

15

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

LEBRIKIZUMAB

Brand Name : EBGLYSS

Dosage Form : SOLUTION

Dosage Strength : 250MG/2ML

Packaging :

Approval Date :

Application Number : 2549123

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

16

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

LEBRIKIZUMAB

Brand Name : EBGLYSS

Dosage Form : SOLUTION

Dosage Strength : 250MG/2ML

Packaging :

Approval Date :

Application Number : 2549131

Regulatory Info : SCHEDULE D

Registration Country : Canada

blank